FeesSafety
Pluang+

Vivani Medical raises $5.1M in private stock sale to fund semaglutide implant development.

Company Fundamentals
16 Nov 2026, 12:30 WIB
GlobeNewsWire
View Source
Bullish
Vivani Medical raises $5.1M in private stock sale to fund semaglutide implant development.

Vivani Medical announced a private placement of 5,049,506 shares at $1.01 each, raising approximately $5.1 million. The funding will support ongoing research and clinical trials for its semaglutide implant NPM-139 and other products. This follows positive Phase 1 trial results showing the implant's safety and comparable efficacy to weekly injections. The company expects the proceeds to fund operations into Q3 2027 and plans a Phase 2 trial in 2027.

Vivani Medical's private placement equity financing is context for readers following health stocks. For readers following health stocks, here is Pluang's market snapshot as of Nov 16, 2026 15:41 WIB: Out of 150 priced US health-sector stocks, 60 rose and 86 fell. Notable movers include Summit Therapeutics Inc (SMMT) down 19.93% at USD 11.33, Aveanna Healthcare Holdings Inc (AVAH) down 12.15% at USD 11.50, and Citius Pharmaceuticals Inc (CTXR) up 11.34% at USD 0.54. Typical hold times range from 12 to 20 days on Pluang.

More News

Credit Agricole Toulouse 31 reports weekly transactions on cooperative investment certificates.

Credit Agricole Toulouse 31 reports weekly transactions on cooperative investment certificates.

Credit Agricole Toulouse 31 disclosed its weekly transactions on cooperative investment certificates (CCI) for the period from November 9 to November 13, 2026. The report details daily volumes and average acquisition prices, showing active buybacks o...

Market News
Neutral
52 minutes ago
Euronet and Getnet integrate VAT refund into payment terminals for smoother Tax Free shopping in Spain.

Euronet and Getnet integrate VAT refund into payment terminals for smoother Tax Free shopping in Spain.

Euronet and Getnet, Santander Group's payment platform, have partnered to integrate VAT refund services directly into payment terminals in Spain. This collaboration allows merchants to process Tax Free transactions seamlessly at the point of sale, si...

Market News
Bullish
52 minutes ago
Danske Bank buys back 25,000 shares in week 46, continuing its DKK 4.5 billion buy-back program.

Danske Bank buys back 25,000 shares in week 46, continuing its DKK 4.5 billion buy-back program.

Danske Bank executed transactions to repurchase 25,000 shares during week 46 as part of its ongoing share buy-back program announced in February 2026. The program targets a total buy-back of up to DKK 4.5 billion or 45 million shares by January 2027....

Company Fundamentals
Neutral
1 hour ago
French firms boost AI-driven cybersecurity, focusing on productivity and operational results over processes.

French firms boost AI-driven cybersecurity, focusing on productivity and operational results over processes.

A new study by Securonix shows French organizations are increasingly adopting AI-driven cybersecurity operations, prioritizing productivity and measurable outcomes rather than just processes. French firms lead in allowing AI to automatically trigger ...

Market News
Neutral
2 hours ago
Lakefront Biotherapeutics launches new €50M share buyback after completing initial program

Lakefront Biotherapeutics launches new €50M share buyback after completing initial program

Lakefront Biotherapeutics has started a new €50 million share buyback program following the completion of its initial €50 million program, in which it repurchased about 1.99 million shares. The new program, running until March 31, 2027, aims to enhan...

Company Fundamentals
Bullish
4 hours ago
banner-footerbanner-footer

Invest & Trade with
#1 Award-Winning Investment Super App